-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Lifecore Biomedical, Inc. \De\ quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q2 2012 to Q2 2024.
- Lifecore Biomedical, Inc. \De\ Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending May 26, 2024 was $40.8M, a 8.54% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)